Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MM2 Group, Inc. was a healthcare company primarily focused on the formulation, marketing, and distribution of nutritional supplements and vitamins. Operating through its subsidiary, Genotec Nutritionals, the company engaged in the nutraceuticals market and established a joint venture in China with Anshi Pharmaceutical to manufacture softgel capsules. Although it was publicly traded under the symbol MMGP, the company eventually pivoted away from the healthcare sector, and its SEC registration under the MM2 name was revoked in 2011. During its operation, the company's business model centered on internal growth and the acquisition of other entities within the dietary supplement industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on mm2 Group.